Equities research analysts expect Varian Medical Systems, Inc. (NYSE:VAR) to report earnings per share (EPS) of $1.03 for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for Varian Medical Systems’ earnings, with estimates ranging from $0.94 to $1.13. Varian Medical Systems reported earnings per share of $0.89 during the same quarter last year, which indicates a positive year over year growth rate of 15.7%. The company is expected to issue its next earnings report on Wednesday, April 25th.

On average, analysts expect that Varian Medical Systems will report full year earnings of $4.31 per share for the current fiscal year, with EPS estimates ranging from $4.25 to $4.36. For the next financial year, analysts forecast that the firm will report earnings of $4.78 per share, with EPS estimates ranging from $4.65 to $5.02. Zacks’ EPS calculations are an average based on a survey of sell-side research firms that that provide coverage for Varian Medical Systems.

Get Varian Medical Systems alerts:

Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings data on Wednesday, January 24th. The medical equipment provider reported $1.06 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.00 by $0.06. The company had revenue of $678.50 million for the quarter, compared to analysts’ expectations of $633.96 million. Varian Medical Systems had a net margin of 4.27% and a return on equity of 27.13%. Varian Medical Systems’s revenue for the quarter was up 12.8% compared to the same quarter last year. During the same period in the prior year, the business earned $1.09 earnings per share.

A number of analysts have recently weighed in on VAR shares. BTIG Research reissued a “hold” rating on shares of Varian Medical Systems in a research note on Sunday, January 28th. JPMorgan Chase & Co. increased their price objective on Varian Medical Systems from $88.00 to $105.00 and gave the company a “neutral” rating in a research note on Thursday, January 25th. Citigroup increased their price objective on Varian Medical Systems from $128.00 to $132.00 and gave the company a “buy” rating in a research note on Thursday, January 25th. Royal Bank of Canada increased their price objective on Varian Medical Systems to $115.00 and gave the company a “sector perform” rating in a research note on Thursday, January 25th. Finally, Zacks Investment Research raised Varian Medical Systems from a “sell” rating to a “hold” rating in a research note on Monday, January 29th. Three analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $106.40.

In other Varian Medical Systems news, Director Mark R. Laret sold 2,161 shares of the stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $126.97, for a total value of $274,382.17. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Dow R. Wilson sold 88,766 shares of the stock in a transaction on Monday, December 18th. The stock was sold at an average price of $111.00, for a total value of $9,853,026.00. Following the completion of the transaction, the insider now owns 155,542 shares of the company’s stock, valued at approximately $17,265,162. The disclosure for this sale can be found here. Insiders sold 139,842 shares of company stock valued at $15,923,110 in the last ninety days. 0.78% of the stock is currently owned by insiders.

Institutional investors and hedge funds have recently bought and sold shares of the business. Hardman Johnston Global Advisors LLC raised its holdings in Varian Medical Systems by 0.5% in the third quarter. Hardman Johnston Global Advisors LLC now owns 229,872 shares of the medical equipment provider’s stock worth $23,001,000 after purchasing an additional 1,235 shares in the last quarter. State of Wisconsin Investment Board increased its holdings in shares of Varian Medical Systems by 5.0% during the third quarter. State of Wisconsin Investment Board now owns 85,312 shares of the medical equipment provider’s stock valued at $8,536,000 after acquiring an additional 4,025 shares in the last quarter. California Public Employees Retirement System increased its holdings in shares of Varian Medical Systems by 7.0% during the third quarter. California Public Employees Retirement System now owns 270,898 shares of the medical equipment provider’s stock valued at $27,106,000 after acquiring an additional 17,698 shares in the last quarter. Pinebridge Investments L.P. bought a new position in shares of Varian Medical Systems during the third quarter valued at $277,000. Finally, Neuberger Berman Group LLC increased its holdings in shares of Varian Medical Systems by 1.3% during the third quarter. Neuberger Berman Group LLC now owns 158,198 shares of the medical equipment provider’s stock valued at $15,829,000 after acquiring an additional 2,104 shares in the last quarter. Institutional investors and hedge funds own 99.19% of the company’s stock.

Shares of Varian Medical Systems (NYSE VAR) opened at $116.92 on Monday. The stock has a market capitalization of $10,863.94, a P/E ratio of 93.54, a price-to-earnings-growth ratio of 3.44 and a beta of 0.81. Varian Medical Systems has a 52 week low of $77.73 and a 52 week high of $130.29.

WARNING: “” was originally published by Daily Political and is the property of of Daily Political. If you are reading this story on another domain, it was copied illegally and republished in violation of US & international trademark & copyright laws. The legal version of this story can be read at https://www.dailypolitical.com/2018/02/08/1750847.html.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.